Help us: Donate
Follow us on:

Healthspan Capital

Organization Description

Healthspan Capital is a venture capital firm with a mission to broadly invest and support longevity biotechnology (“LongBio”) companies developing therapeutics to extend healthy human lifespan. They believe that rejuvenation biotechnology is the future of medicine.

Healthspan Capital was founded in 2021 by Sebastian Brunemeier, Nathan Cheng, and Michael Chinen. Their fund was the first publicly accessible longevity venture fund listed on Angel List.


Sebastian A. Brunemeier

Healthspan Capital - General Partner